These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19803703)

  • 1. Current challenges in viral hepatitis, antimicrobial resistance and the influenza pandemic.
    Fung J
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):945-9. PubMed ID: 19803703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza virus resistance to oseltamivir: what are the implications?
    Fleming DM; Elliot AJ; Meijer A; Paget WJ
    Eur J Public Health; 2009 Jun; 19(3):238-9. PubMed ID: 19221019
    [No Abstract]   [Full Text] [Related]  

  • 6. Is hepatitis virus resistance to antiviral drugs a threat?
    Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1369-72. PubMed ID: 22537445
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
    Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
    Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swine flu outbreak. What role for antiviral drugs?
    Couzin-Frankel J
    Science; 2009 May; 324(5928):705. PubMed ID: 19423784
    [No Abstract]   [Full Text] [Related]  

  • 10. [A report from the Chinese National Fourteenth Symposium on Viral Hepatitis and Liver Diseases].
    Zhu HM; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):636-7. PubMed ID: 19719931
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza A/H1N1 in 2009: a pandemic in evolution.
    Clark T; Stephenson I
    Expert Rev Vaccines; 2009 Jul; 8(7):819-22. PubMed ID: 19538107
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of chronic hepatitis B and the implications of viral resistance to therapy.
    Mauss S; Wedemeyer H
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):191-9. PubMed ID: 18380601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of oseltamivir-resistant influenza A/H1N1 virus of different origins in Yokohama City, Japan, during the 2007-2008 influenza season.
    Kawakami C; Obuchi M; Saikusa M; Noguchi Y; Ujike M; Odagiri T; Iwata M; Toyozawa T; Tashiro M
    Jpn J Infect Dis; 2009 Jan; 62(1):83-6. PubMed ID: 19168972
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of antiviral resistance in patients with chronic hepatitis B.
    Locarnini S; Hatzakis A; Heathcote J; Keeffe EB; Liang TJ; Mutimer D; Pawlotsky JM; Zoulim F
    Antivir Ther; 2004 Oct; 9(5):679-93. PubMed ID: 15535405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic viral hepatitis as a public health issue in the world.
    Lavanchy D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):991-1008. PubMed ID: 19187863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run].
    Uhnoo I; Bergquist C
    Lakartidningen; 2009 Jul 8-21; 106(28-29):1814-9. PubMed ID: 19685621
    [No Abstract]   [Full Text] [Related]  

  • 17. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
    Locarnini S; Warner N
    Antivir Ther; 2007; 12 Suppl 3():H15-23. PubMed ID: 18284179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: influenza activity - United States, August 30-October 31, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1236-41. PubMed ID: 19910911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.